166 related articles for article (PubMed ID: 32188269)
41. A panel of circulating long non-coding RNAs as liquid biopsy biomarkers for breast and cervical cancers.
Barwal TS; Sharma U; Vasquez KM; Prakash H; Jain A
Biochimie; 2020 Sep; 176():62-70. PubMed ID: 32634463
[TBL] [Abstract][Full Text] [Related]
42. Plasma Exosomal Long Non-Coding RNAs Serve as Biomarkers for Early Detection of Colorectal Cancer.
Hu D; Zhan Y; Zhu K; Bai M; Han J; Si Y; Zhang H; Kong D
Cell Physiol Biochem; 2018; 51(6):2704-2715. PubMed ID: 30562751
[TBL] [Abstract][Full Text] [Related]
43. Rapid Isolation and Detection of Exosomes and Associated Biomarkers from Plasma.
Ibsen SD; Wright J; Lewis JM; Kim S; Ko SY; Ong J; Manouchehri S; Vyas A; Akers J; Chen CC; Carter BS; Esener SC; Heller MJ
ACS Nano; 2017 Jul; 11(7):6641-6651. PubMed ID: 28671449
[TBL] [Abstract][Full Text] [Related]
44. Systematic review: exosomal microRNAs associated with pancreatic cancer for early detection and prognosis.
Ye H; Wang H; Wang P; Song CH; Wang KJ; Dai LP; Shi JX; Liu XX; Sun CQ; Wang X; Peng Y; Chen XB; Zhang JY
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9351-9361. PubMed ID: 31773694
[TBL] [Abstract][Full Text] [Related]
45. Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers.
Hamam R; Hamam D; Alsaleh KA; Kassem M; Zaher W; Alfayez M; Aldahmash A; Alajez NM
Cell Death Dis; 2017 Sep; 8(9):e3045. PubMed ID: 28880270
[TBL] [Abstract][Full Text] [Related]
46. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
47. Circulating tumor cells and cell-free nucleic acids in patients with gynecological malignancies.
Davidson B
Virchows Arch; 2018 Oct; 473(4):395-403. PubMed ID: 30145616
[TBL] [Abstract][Full Text] [Related]
48. Circulating thyroid stimulating hormone receptor messenger RNA and differentiated thyroid cancer: A diagnostic meta-analysis.
Zhang ZZ; Chen Q; Kong CY; Li ZM; Wang LS
Oncotarget; 2017 Jan; 8(4):6623-6629. PubMed ID: 28036261
[TBL] [Abstract][Full Text] [Related]
49. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients.
Castillo J; Bernard V; San Lucas FA; Allenson K; Capello M; Kim DU; Gascoyne P; Mulu FC; Stephens BM; Huang J; Wang H; Momin AA; Jacamo RO; Katz M; Wolff R; Javle M; Varadhachary G; Wistuba II; Hanash S; Maitra A; Alvarez H
Ann Oncol; 2018 Jan; 29(1):223-229. PubMed ID: 29045505
[TBL] [Abstract][Full Text] [Related]
50. Cell-free miRNAs as non-invasive biomarkers in breast cancer: Significance in early diagnosis and metastasis prediction.
Kashyap D; Kaur H
Life Sci; 2020 Apr; 246():117417. PubMed ID: 32044304
[TBL] [Abstract][Full Text] [Related]
51. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer.
Tsukamoto M; Iinuma H; Yagi T; Matsuda K; Hashiguchi Y
Oncology; 2017; 92(6):360-370. PubMed ID: 28376502
[TBL] [Abstract][Full Text] [Related]
52. Circulating exosomal miRNAs: clinical significance in human cancers.
Avgeris M; Panoutsopoulou K; Papadimitriou MA; Scorilas A
Expert Rev Mol Diagn; 2019 Nov; 19(11):979-995. PubMed ID: 31594418
[No Abstract] [Full Text] [Related]
53. Exosomal miRNAs as novel cancer biomarkers: Challenges and opportunities.
Salehi M; Sharifi M
J Cell Physiol; 2018 Sep; 233(9):6370-6380. PubMed ID: 29323722
[TBL] [Abstract][Full Text] [Related]
54. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
[TBL] [Abstract][Full Text] [Related]
55. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
Zhang W; Ni M; Su Y; Wang H; Zhu S; Zhao A; Li G
Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793
[TBL] [Abstract][Full Text] [Related]
56. Non-coding RNAs Enabling Prognostic Stratification and Prediction of Therapeutic Response in Colorectal Cancer Patients.
Perakis SO; Thomas JE; Pichler M
Adv Exp Med Biol; 2016; 937():183-204. PubMed ID: 27573901
[TBL] [Abstract][Full Text] [Related]
57. Exosomal miRNAs as biomarkers of recurrent lung cancer.
Munagala R; Aqil F; Gupta RC
Tumour Biol; 2016 Aug; 37(8):10703-14. PubMed ID: 26867772
[TBL] [Abstract][Full Text] [Related]
58. Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer.
Matsumura T; Sugimachi K; Iinuma H; Takahashi Y; Kurashige J; Sawada G; Ueda M; Uchi R; Ueo H; Takano Y; Shinden Y; Eguchi H; Yamamoto H; Doki Y; Mori M; Ochiya T; Mimori K
Br J Cancer; 2015 Jul; 113(2):275-81. PubMed ID: 26057451
[TBL] [Abstract][Full Text] [Related]
59. Exosomal miR-126 as a circulating biomarker in non-small-cell lung cancer regulating cancer progression.
Grimolizzi F; Monaco F; Leoni F; Bracci M; Staffolani S; Bersaglieri C; Gaetani S; Valentino M; Amati M; Rubini C; Saccucci F; Neuzil J; Tomasetti M; Santarelli L
Sci Rep; 2017 Nov; 7(1):15277. PubMed ID: 29127370
[TBL] [Abstract][Full Text] [Related]
60. Stimuli-Mediated Specific Isolation of Exosomes from Blood Plasma for High-Throughput Profiling of Cancer Biomarkers.
Liu X; Zong Z; Liu X; Li Q; Li A; Xu C; Liu D
Small Methods; 2022 Feb; 6(2):e2101234. PubMed ID: 35174989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
